Literature DB >> 3143808

Incubation periods in six models of intraperitoneally injected scrapie depend mainly on the dynamics of agent replication within the nervous system and not the lymphoreticular system.

R H Kimberlin1, C A Walker.   

Abstract

The pathogenesis of intraperitoneally injected ME7 scrapie has been studied in two Sinc genotypes of mice which gave predictable but widely different incubation periods. Comparisons were made with three other mouse scrapie models and one model in hamsters (involving different strains of agent and an untyped isolate from sheep). Average incubation periods ranged from 114 days in the fastest model (263K/hamsters) to 482 days in the slowest (ME7/Sincp7 mice). There were only small differences between models in the times of onset of replication in spleen and cervical lymph nodes. We suggest that the lymphoreticular stage of pathogenesis initiates neuroinvasion in the peripheral nervous system within a few days to a few weeks of infection. Thereafter, pathogenesis appears to be dominated by neural events and replication in brain becomes detectable after approximately 54% of the remaining incubation period has elapsed, irrespective of its length. It is concluded that the differences between incubation periods of the six scrapie models depend mainly on the rate of a continuous process of replication and spread of infection in the peripheral and central nervous system, which is predetermined by scrapie strain and host genotype. The unpredictability of some other scrapie models (and the natural disease) could be explained by additional factors which restrict neuroinvasion from the lymphoreticular system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143808     DOI: 10.1099/0022-1317-69-12-2953

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Autonomic nervous system innervation of lymphoid territories in spleen: a possible involvement of noradrenergic neurons for prion neuroinvasion in natural scrapie.

Authors:  A Bencsik; S Lezmi; T Baron
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

Review 2.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Alteration of B-cell subsets enhances neuroinvasion in mouse scrapie infection.

Authors:  Christine von Poser-Klein; Eckhard Flechsig; Tanja Hoffmann; Petra Schwarz; Harry Harms; Raymond Bujdoso; Adriano Aguzzi; Michael A Klein
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

4.  Correlation analysis for the incubation period of prion disease.

Authors:  Se-Eun Bae; Sunghoon Jung; Ha-Yeon Kim; Hyeon S Son
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

5.  Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen.

Authors:  R Race; M Oldstone; B Chesebro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 6.  Transmissible encephalopathies in animals.

Authors:  R H Kimberlin
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

7.  Generation of novel neuroinvasive prions following intravenous challenge.

Authors:  Patricia Aguilar-Calvo; Cyrus Bett; Alejandro M Sevillano; Timothy D Kurt; Jessica Lawrence; Katrin Soldau; Per Hammarström; K Peter R Nilsson; Christina J Sigurdson
Journal:  Brain Pathol       Date:  2018-07-05       Impact factor: 6.508

8.  Scrapie infections initiated at varying doses: an analysis of 117 titration experiments.

Authors:  A R McLean; C J Bostock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

9.  Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.

Authors:  Fabienne Archer; Corinne Bachelin; Olivier Andreoletti; Nathalie Besnard; Gregory Perrot; Christelle Langevin; Annick Le Dur; Didier Vilette; Anne Baron-Van Evercooren; Jean-Luc Vilotte; Hubert Laude
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Immune system-dependent and -independent replication of the scrapie agent.

Authors:  C I Lasmézas; J Y Cesbron; J P Deslys; R Demaimay; K T Adjou; R Rioux; C Lemaire; C Locht; D Dormont
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.